Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59468-9 Hemoglobin EntSub RBC Pt Qn     ACTIVE MCH [Entitic substance]   NAM DefinitionDescription     fmol             HEM/BC   59468-9         Observation       0 MCH EntSub RBC       N   Entitic substance; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.79 2.32               fmol     Release 2.79: COMPONENT: Triggered by Coll w SCT: Precoordination of the component with Property: mean concentration; the decision was to post coordinate and separate component and property; Previous Releases: Changed Short name 'Erythrocyte mean corpuscular hemoglobin' to 'MCH' for succinctness. 0
5947-7 Coagulation surface induced.factor substitution^20M post incubation after addition of normal plasma Time PPP^Control Pt Qn Coag   ACTIVE aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma   MAJ DefinitionDescription     s             COAG   5947-7   Coag     Observation       0 aPTT 20M NP Cont PPP       Y   20M NP; 20M p Inc; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; Hematology; Heme; Little(A)PTT; Mixing studies; Normal; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube 2.52 1.0d               s       0
59470-5 Calcium.ionized MCnc BldA Pt Qn     ACTIVE Calcium.ionized [Mass/volume] in Arterial blood   MIN DefinitionDescription     mg/dL             CHEM   59470-5         Both       0 Ca-I BldA-mCnc       N   ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 2.34               mg/dL       0
59471-3 Calcium.ionized MCnc BldV Pt Qn     ACTIVE Calcium.ionized [Mass/volume] in Venous blood   MIN DefinitionDescription     mg/dL             CHEM   59471-3         Both       0 Ca-I BldV-mCnc       N   Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous 2.73 2.34               mg/dL       0
59472-1 Calcium.ionized^^adjusted to pH 7.4 MCnc BldA Pt Qn ISE   ACTIVE Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE)   MIN DefinitionDescription     mg/dL             CHEM   59472-1   ISE     Both       0 Ca-I adj pH7.4 BldA ISE-mCnc       N   ABG; adj; adj pH7.4; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 2.34               mg/dL       0
59473-9 Calcium.ionized^^adjusted to pH 7.4 MCnc BldV Pt Qn ISE   ACTIVE Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Venous blood by Ion-selective membrane electrode (ISE)   MIN DefinitionDescription     mg/dL             CHEM   59473-9   ISE     Both       0 Ca-I adj pH7.4 BldV ISE-mCnc       N   adj; adj pH7.4; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous 2.7 2.34               mg/dL       0
59474-7 Observation Prid CSF Pt Nom Acridine orange stain   ACTIVE Microscopic observation [Identifier] in Cerebral spinal fluid by Acridine orange stain   NAM DefinitionDescription                   MICRO   59474-7   Acridine orange stain     Both       0 AO Stn CSF       N   AO; AO Stn; Cerebral spinal fluid; Cerebrospinal Fl; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St; Stains; Stn 2.78 2.32                     Release 2.78: COMPONENT: Updated to seperate the component from the method; 0
59475-4 Collaborative staging metastasis at diagnosis - bone involvement Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging metastasis at diagnosis - bone involvement Cancer   MIN DefinitionDescription                   TUMRRGT   59475-4                 0 CS mets at Dx - bone Cancer       N   CA; CS; CS mets at Dx; CS mets at Dx - bone; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified 2.34 2.34                       0
59476-2 Collaborative staging metastasis at diagnosis - brain involvement Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging metastasis at diagnosis - brain involvement Cancer   MIN DefinitionDescription                   TUMRRGT   59476-2                 0 CS mets at Dx - brain Cancer       N   CA; CS; CS mets at Dx; CS mets at Dx - brain; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified 2.34 2.34                       0
59477-0 Collaborative staging metastasis at diagnosis - liver involvement Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging metastasis at diagnosis - liver involvement Cancer   MIN DefinitionDescription                   TUMRRGT   59477-0                 0 CS mets at Dx - liver Cancer       N   CA; CS; CS mets at Dx; CS mets at Dx - liver; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified 2.34 2.34                       0
59478-8 Collaborative staging metastasis at diagnosis - lung involvement Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging metastasis at diagnosis - lung involvement Cancer   MIN DefinitionDescription                   TUMRRGT   59478-8                 0 CS mets at Dx - lung Cancer       N   CA; CS; CS mets at Dx; CS mets at Dx - lung; Dx; Identity or presence; Lung; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified 2.34 2.34                       0
59479-6 Collaborative staging post treatment extension Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging post treatment extension Cancer   MIN DefinitionDescription                   TUMRRGT   59479-6                 0 CS post Rx ext Cancer       N   After; CA; CS; CS post Rx ext; EXT; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
5948-5 Coagulation surface induced.factor substitution^immediately after addition of normal plasma Time PPP Pt Qn Coag   DEPRECATED Deprecated Activated partial thrombplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma   DEL DefinitionDescription     s             COAG   5948-5   Coag             0 Deprecated aPTT imm NP PPP Qn           Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube 2.4 1.0d       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59480-4 Collaborative staging post treatment lymph nodes Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging post treatment lymph nodes Cancer   MIN DefinitionDescription                   TUMRRGT   59480-4                 0 CS post Rx LN Cancer       N   After; CA; CS; CS post Rx LN; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59481-2 Collaborative staging post treatment metastasis at diagnosis Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging post treatment metastasis at diagnosis Cancer   MIN DefinitionDescription                   TUMRRGT   59481-2                 0 CS post Rx mets at Dx Cancer       N   After; CA; CS; CS post Rx mets at Dx; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59482-0 Collaborative staging post treatment tumor size Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging post treatment tumor size Cancer   MIN DefinitionDescription                   TUMRRGT   59482-0                 0 CS post Rx tumor size Cancer       N   After; CA; CS; CS post Rx tumor size; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59483-8 Collaborative staging pre treatment lymph nodes Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging pre treatment lymph nodes Cancer   MIN DefinitionDescription                   TUMRRGT   59483-8                 0 CS pre Rx LN Cancer       N   Before; CA; CS; CS pre Rx LN; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59484-6 Collaborative staging pre treatment metastasis at diagnosis Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging pre treatment metastasis at diagnosis Cancer   MIN DefinitionDescription                   TUMRRGT   59484-6                 0 CS pre Rx mets at Dx Cancer       N   Before; CA; CS; CS pre Rx mets at Dx; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59485-3 Collaborative staging pre treatment metastasis evaluation Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging pre treatment metastasis evaluation Cancer   MIN DefinitionDescription                   TUMRRGT   59485-3                 0 CS pre Rx mets eval Cancer       N   Assessment; Before; CA; CS; CS pre Rx mets eval; Eval; H&P; History and physical; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59486-1 Collaborative staging pre treatment regional nodes evaluation Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging pre treatment regional nodes evaluation Cancer   MIN DefinitionDescription                   TUMRRGT   59486-1                 0 CS pre Rx reg nodes eval Cancer       N   Assessment; Before; CA; CS; CS pre Rx reg nodes eval; Eval; H&P; History and physical; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59487-9 Collaborative staging pre treatment tumor size and extension evaluation Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging pre treatment tumor size and extension evaluation Cancer   MIN DefinitionDescription                   TUMRRGT   59487-9                 0 CS pre Rx tumor size/ext eval Cancer       N   Assessment; Before; CA; CS; CS pre Rx tumor size; CS pre Rx tumor size/ext eval; Eval; EXT; H&P; History and physical; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59488-7 Collaborative staging pre treatment tumor size Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging pre treatment tumor size Cancer   MIN DefinitionDescription                   TUMRRGT   59488-7                 0 CS pre Rx tumor size Cancer       N   Before; CA; CS; CS pre Rx tumor size; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified 2.34 2.34                       0
59489-5 Collaborative staging site-specific factor 7 Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging site-specific factor 7 Cancer   MIN DefinitionDescription                   TUMRRGT   59489-5                 0 CS site-specific factor 7 Cancer       N   CA; CS; CS site-specific factor 7; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified 2.34 2.34                       0
5949-3 Coagulation surface induced.factor substitution^immediately after addition of normal plasma Time PPP^Control Pt Qn Coag   ACTIVE aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma   MIN DefinitionDescription     s             COAG   5949-3   Coag     Observation       0 aPTT imm NP Cont PPP       Y   Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Normal; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube 2.73 1.0d               s       0
59490-3 Collaborative staging site-specific factor 8 Prid Cancer.XXX Pt Nom     ACTIVE Collaborative staging site-specific factor 8 Cancer   MIN DefinitionDescription                   TUMRRGT   59490-3                 0 CS site-specific factor 8 Cancer       N   CA; CS; CS site-specific factor 8; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified 2.34 2.34                       0
104,672 results found